Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

U Regenass

Showing results (21-30 of 34) with videos related to

Pageof 4
Sort By:
The Journal of Antibiotics|November 1, 1995
Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodinA Fredenhagen, H Mett, T Meyer, et al.
International Journal of Cancer|May 15, 1989
A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activityT Meyer, U Regenass, D Fabbro, et al.
International Journal of Cancer|June 25, 1998
Reversal of multidrug resistance by the staurosporine derivatives CGP 41251 and CGP 42700I Utz, M Spitaler, M Rybczynska, et al.
International Journal of Cancer|May 21, 1999
Author errataT Meyer, U Regenass, D Fabbro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analoguesH Mett, J Stanek, J A Lopez-Ballester, et al.
Journal of Medicinal Chemistry|June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinaseP Traxler, U Trinks, E Buchdunger, et al.
Cancer Research|September 1, 1992
New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activityU Regenass, G Caravatti, H Mett, et al.
Journal of Medicinal Chemistry|April 1, 1994
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinaseU Trinks, E Buchdunger, P Furet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activityE Buchdunger, H Mett, U Trinks, et al.
The Journal of Biological Chemistry|December 25, 1990
Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitorsJ F Geissler, P Traxler, U Regenass, et al.
Pageof 4

Showing results (21-30 of 34) with videos related to

Sort By:
Pageof 4
The Journal of Antibiotics|November 1, 1995
Protein tyrosine kinase and protein kinase C inhibition by fungal anthraquinones related to emodinA Fredenhagen, H Mett, T Meyer, et al.
International Journal of Cancer|May 15, 1989
A derivative of staurosporine (CGP 41 251) shows selectivity for protein kinase C inhibition and in vitro anti-proliferative as well as in vivo anti-tumor activityT Meyer, U Regenass, D Fabbro, et al.
International Journal of Cancer|June 25, 1998
Reversal of multidrug resistance by the staurosporine derivatives CGP 41251 and CGP 42700I Utz, M Spitaler, M Rybczynska, et al.
International Journal of Cancer|May 21, 1999
Author errataT Meyer, U Regenass, D Fabbro, et al.
Cancer Chemotherapy and Pharmacology|January 1, 1993
Pharmacological properties of the ornithine decarboxylase inhibitor 3-aminooxy-1-propanamine and several structural analoguesH Mett, J Stanek, J A Lopez-Ballester, et al.
Journal of Medicinal Chemistry|June 23, 1995
[(Alkylamino)methyl]acrylophenones: potent and selective inhibitors of the epidermal growth factor receptor protein tyrosine kinaseP Traxler, U Trinks, E Buchdunger, et al.
Cancer Research|September 1, 1992
New S-adenosylmethionine decarboxylase inhibitors with potent antitumor activityU Regenass, G Caravatti, H Mett, et al.
Journal of Medicinal Chemistry|April 1, 1994
Dianilinophthalimides: potent and selective, ATP-competitive inhibitors of the EGF-receptor protein tyrosine kinaseU Trinks, E Buchdunger, P Furet, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 1, 1995
4,5-bis(4-fluoroanilino)phthalimide: A selective inhibitor of the epidermal growth factor receptor signal transduction pathway with potent in vivo antitumor activityE Buchdunger, H Mett, U Trinks, et al.
The Journal of Biological Chemistry|December 25, 1990
Thiazolidine-diones. Biochemical and biological activity of a novel class of tyrosine protein kinase inhibitorsJ F Geissler, P Traxler, U Regenass, et al.
Pageof 4